isopropyl alcohol
Approved
Jul 14, 2000
Isopropanolamine (1-Amino-2-propanol) is a colorless to yellowish liquid with an amine-like odor. It is miscible in water. Intermediate used in the production of dyes, lubrification oils, corrosion inhibitor, detergents, cutting fluids. — NCATS
Clinical trial activity
47 trials · 52 clinical orgs · 6 marketing orgs
Earliest trial started May 1, 2002 (NCT00515151)
Timeline
1950s
- Jun 1, 1954
Evidence of US Marketing
2000s
- Jul 14, 2000
Earliest FDA Approval
- Jul 14, 2000
Becton Dickinson — NDA Secondary Org
- Jun 3, 2005
PDI Healthcare — NDA Secondary Org
- Sep 29, 2006
3M — NDA Secondary Org
- Sep 29, 2006
Graceway — NDA Secondary Org
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
2010s
- Jan 1, 2011
Earliest Phase 3 Sponsor(trial)
- Jan 1, 2015
- Aug 8, 2018
Bausch Health Companies — NDA Secondary Org
- Apr 26, 2019
Zurex Pharma, Inc. — Marketing Organization
- Apr 26, 2019
Zurex Pharma, Inc. — NDA Secondary Org
Indications
Approved for
Studied for
- Ankle · Phase 4
- Arthroplasty, Replacement, Hip · Phase 4
- Bacteremia · Phase 4
- Bacteria · Phase 3
- Bacterial Infections · Phase 4
- Catheterization, Central Venous · Phase 4
- Catheter-Related Infections · Phase 4
- Cesarean Section · Phase 4
- Chemical Actions and Uses · Early Phase 1
- Communicable Diseases · Phase 3
- Dermatology · Phase 3
- Fractures, Bone · Phase 3
- Gastrointestinal Microbiome · Phase 4
- General Surgery · Phase 4
- Healthy Volunteers · Phase 4
- Nausea · Phase 4
- Only Child · Phase 2/Phase 3
- Opioid-Related Disorders · Phase 4
- Pharmacology · Phase 4
- Prostatic Neoplasms · Phase 2
- Sepsis · Phase 4
- Soft Tissue Infections · Phase 4
- Surgical Wound Infection · Phase 4
- Vomiting · Phase 2/Phase 3
- Warts · Phase 3
Mechanism of action
- UnclearUnclear
Unclear unclear
Combination products
chloraprep one-step
with chlorhexidine
Also known as chloraprep one-step frepp, chloraprep one-step sepp, chloraprep single swabstick, chloraprep triple swabstick, chloraprep with tint, prevantics maxi swabstick, prevantics swab, prevantics swabstick
duraprep
with iodine povacrylex
Approval history
- approvedJul 14, 2000
- approvedJun 1, 1954
Chemistry & pharmacology
SMILES
CC(C)O- Mol. weight
- 60.095 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
- Availability
- Over the Counter
Oral
No
Parenteral
No
Topical
Yes
Sources
- WikipediaIsopropyl alcohol ↗
- NCATSND2M416302 ↗
- ChEMBLCHEMBL582 ↗
Also known as
- 2-propanol
- 2-propanol
- 2-propanol
- 2-propanol
- chlorhexidine gluconate mixture with isopropyl alcohol
- duraprep
- ipa
- ipa
- ipa
- isopropanol
- isopropanol
- isopropanol
- isopropanol
- isopropanol
- isopropanol
- iso-propanol
- isopropyl alcohol
- isopropyl alcohol
- isopropyl alcohol
- isopropyl alcohol
- isopropyl alcohol
- isopropyl alcohol
- isopropyl alcohol
- isopropyl alcohol
- manugel
- manugel
- medi-swab
- medi-swab h
- riboprine
- riboprine
- sterets
- sterets h
- swim-ear
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06836271 | Phase 2 | Mar 1, 2025 | Hitit University |
| NCT05920122 | Phase 4 | Oct 9, 2023 | University of Pittsburgh |
| NCT05418244 | Phase 2/Phase 3 (Phase 3) | Apr 20, 2022 | State University of New York, Buffalo |
| NCT05401292 | Phase 4 | Feb 15, 2022 | University of Missouri |
| NCT05175521 | N/A | Nov 11, 2021 | HonorHealth Research Institute |
| NCT04756804 | Phase 3 | Jun 21, 2021 | Medical College of Wisconsin, Zurex Pharma, Inc. |
| NCT04464915 | N/A | Jul 31, 2020 | University of Ottawa |
| NCT04756154 | Phase 3 | Jul 6, 2020 | 3M, Microbac |
| NCT04307550 | Phase 1/Phase 2 (Phase 2) | Jun 19, 2020 | University of Calgary |
| NCT04218110 | Phase 3 | Feb 11, 2020 | Eurofins, PDI Healthcare |
| NCT04181463 | N/A | Jan 31, 2020 | National Cancer Institute (NCI), University of Texas at Houston |
| NCT03859908 | Phase 4 | Apr 5, 2019 | Universidad del Salvador |
| NCT03782103 | Phase 3 | Jan 25, 2019 | Zurex Pharma, Inc. |
| NCT06733506 | Phase 4 | Oct 1, 2018 | University of Illinois at Chicago |
| NCT03489512 | Phase 4 | Oct 1, 2018 | University of Valencia |
| NCT03691831 | Phase 3 | Sep 17, 2018 | Aclaris Therapeutics, Inc. |
| NCT03560193 | Phase 4 | Sep 10, 2018 | University of Poitiers |
| NCT03523962 | Phase 3 | Aug 21, 2018 | McMaster University, Patient-Centered Outcomes Research Institute, University of Maryland |
| NCT03417661 | Phase 3 | Jun 29, 2018 | Gama Healthcare Ltd. |
| NCT03224299 | Phase 2 | Jun 21, 2017 | Becton Dickinson |
Organizations
Research & Development (52)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| 3M | For profit | 11 | 8 | 4 | 2010 |
| MicroBioTest | For profit | 4 | 0 | 3 | 2011 |
| CareFusion | For profit | 3 | 3 | 2 | 2007 |
| Universidad de Guanajuato | Academic/Hospital | 2 | 2 | 1 | 2011 |
| Zurex Pharma, Inc. | For profit | 2 | 2 | 1 | 2019 |
| Aclaris Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2018 |
| Antisepsia Central | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Becton Dickinson | For profit | 1 | 1 | 1 | 2017 |
| Bio-Science Laboratories | For profit | 1 | 0 | 1 | 2013 |
| Case Western Reserve University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Centers for Disease Control and Prevention (CDC) | Government | 1 | 0 | 1 | 2012 |
| Cyberderm Inc. | For profit | 1 | 0 | 1 | 2010 |
| Eurofins | For profit | 1 | 0 | 1 | 2020 |
| Gama Healthcare Ltd. | For profit | 1 | 1 | 1 | 2018 |
| Hitit University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| HonorHealth Research Institute | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Johns Hopkins University | Academic/Hospital | 1 | 1 | 1 | 2008 |
| Johnson and Johnson | For profit | 1 | 1 | 1 | 2015 |
| Lakehead University | Academic/Hospital | 1 | 1 | 1 | 2014 |
Marketing (9)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| 3M | For profit | NDA | — |
| 3M | For profit | NDA2 | Sep 29, 2006 |
| 3M | For profit | SYN | Aug 8, 2018 |
| Bausch Health Companies | For profit | NDA2 | Aug 8, 2018 |
| Becton Dickinson | For profit | NDA2 | Jul 14, 2000 |
| Graceway | For profit | NDA2 | Sep 29, 2006 |
| PDI Healthcare | For profit | NDA2 | Jun 3, 2005 |
| Zurex Pharma, Inc. | For profit | MKTG | Apr 26, 2019 |
| Zurex Pharma, Inc. | For profit | NDA2 | Apr 26, 2019 |